Refractory Leukemia
specificA leukemia that is resistant to treatment.
11
Centers
2
Active Trials
$4M
Cancer Funding
Top Centers for Refractory Leukemia(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 69.8 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 69.8 |
| 3 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 66.4 |
| 4 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 63.2 |
| 5 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 47.3 |
| 6 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 47.3 |
| 7 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 47.3 |
| 8 | University of Illinois Cancer CenterChicago, IL | 47.3 |
| 9 | Boston University Cancer CenterBoston, MA | 47.3 |
| 10 | 47.3 | |
| 11 | Penn State Cancer InstituteHershey, PA | 47.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →